Boehringer Ingelheim Obesity Drug Shows Fat-Specific Weight Loss in Late-Stage Trial

Late-stage trial results for Boehringer Ingelheim's obesity drug indicate that it helps patients lose fat rather than muscle, a key finding for weight-loss treatments.